Wide Ranks

IART

Integra LifeSciences Holdings C

24.54

Top Statistics
Market Cap 1 B Forward PE 9.77 Revenue Growth -0.40 %
Current Ratio 1.21 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -0.42 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA 11.16 Enterprise / Revenue 2.31 Price To Sales Trailing12 Months 1.21
Profitability
Profit Margins -0.42 % Operating Margins 6.60 %
Balance Sheet
Total Cash 277 M Total Cash Per Share 3.60 Total Debt 1 B
Total Debt To Equity 130.88 Current Ratio 1.21 Book Value Per Share 19.73
All Measures
Short Ratio 410.00 % Message Board Id finmb_30012 Fax 609 750 4277
Shares Short Prior Month 5 M Return On Equity -0.0042 City Princeton
Uuid 069a3d6c-47d3-32ea-be52-b6fb5f53417c Previous Close 23.70 First Trade Date Epoch Utc 808 M
Book Value 19.73 Beta 1.08 Total Debt 1 B
Volume 379024 Price To Book 1.24 Last Split Date 1 B
Fifty Two Week Low 16.81 Total Cash Per Share 3.60 Total Revenue 1 B
Shares Short Previous Month Date 1 B Target Median Price 25.00 Max Age 86400
Recommendation Mean 3.15 Sand P52 Week Change 0.3133 Operating Margins 6.60 %
Target Mean Price 28.11 Net Income To Common -6545000 Short Percent Of Float 0.0617
Implied Shares Outstanding 77 M Trailing Peg Ratio 82.13 % Last Fiscal Year End 1 B
Average Daily Volume10 Day 854650 Average Volume10days 854650 Total Cash 277 M
Next Fiscal Year End 1 B Revenue Per Share 20.23 Held Percent Insiders 0.0322
Ebitda Margins 20.65 % Trailing PE 0.0000 Date Short Interest 1 B
Most Recent Quarter 1 B Regular Market Previous Close 23.70 Target Low Price 21.00
Gmt Off Set Milliseconds -18000000 Fifty Day Average 20.49 Open 23.62
Free Cashflow 92 M State NJ Dividend Yield 0.00 %
Return On Assets 0.0302 Time Zone Short Name EST Trailing Eps -0.0900
Day Low 23.62 Address1 1100 Campus Road Shares Outstanding 77 M
Price Hint 2 Target High Price 40.00 Website https://www.integralife.com
52 Week Change -0.3738 Average Volume 981620 Forward Eps 2.52
Recommendation Key hold Compensation As Of Epoch Date 1 B Quick Ratio 58.50 %
Last Split Factor 2:1 Regular Market Day High 24.56 Is_sp_500 False
Profit Margins -0.42 % Debt To Equity 130.88 Fifty Two Week High 45.42
Day High 24.56 Shares Short 4 M Regular Market Open 23.62
Industry Key medical-devices Earnings Growth 0.00 % Enterprise To Revenue 2.31
Revenue Growth -0.40 % Shares Percent Shares Out 0.0531 Operating Cashflow 137 M
Currency USD Time Zone Full Name America/New_York Market Cap 1 B
Is_nasdaq_100 False Zip 08540 Quote Type EQUITY
Industry Medical Devices Long Name Integra LifeSciences Holdings Corporation Regular Market Day Low 23.62
Held Percent Institutions 0.9326 Current Price 24.54 Enterprise To Ebitda 11.16
Financial Currency USD Current Ratio 1.21 Gross Margins 59.29 %
Industry Disp Medical Devices Number Of Analyst Opinions 9 Country United States
Float Shares 66 M Two Hundred Day Average 27.08 Enterprise Value 3 B
Price To Sales Trailing12 Months 1.21 Forward PE 9.77 Regular Market Volume 379024
Ebitda 323 M Exchange NMS
Go to Yahoo Finance Go to Seeking Alpha 
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology.

It operates in two segments, Codman Specialty Surgical and Tissue Technologies.

The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services.

It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices.

In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection.

Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products.

The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally.

Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.